Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities

SJ Tabrizi, MD Flower, CA Ross, EJ Wild - Nature Reviews Neurology, 2020 - nature.com
Huntington disease (HD) is a neurodegenerative disease caused by CAG repeat expansion
in the huntingtin gene (HTT) and involves a complex web of pathogenic mechanisms …

Post-translational modifications: regulators of neurodegenerative proteinopathies

R Gupta, M Sahu, D Srivastava, S Tiwari… - Ageing Research …, 2021 - Elsevier
One of the hallmark features in the neurodegenerative disorders (NDDs) is the accumulation
of aggregated and/or non-functional protein in the cellular milieu. Post-translational …

The cryo-electron microscopy structure of huntingtin

Q Guo, B Huang, J Cheng, M Seefelder, T Engler… - Nature, 2018 - nature.com
Huntingtin (HTT) is a large (348 kDa) protein that is essential for embryonic development
and is involved in diverse cellular activities such as vesicular transport, endocytosis …

Huntingtin structure is orchestrated by HAP40 and shows a polyglutamine expansion-specific interaction with exon 1

RJ Harding, JC Deme, JF Hevler, S Tamara… - Communications …, 2021 - nature.com
Huntington's disease results from expansion of a glutamine-coding CAG tract in the
huntingtin (HTT) gene, producing an aberrantly functioning form of HTT. Both wildtype and …

[HTML][HTML] Targeting the proteostasis network in Huntington's disease

TR Soares, SD Reis, BR Pinho, MR Duchen… - Ageing Research …, 2019 - Elsevier
Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by
a polyglutamine expansion mutation in the huntingtin protein. Expansions above 40 …

N-terminal Huntingtin (Htt) phosphorylation is a molecular switch regulating Htt aggregation, helical conformation, internalization, and nuclear targeting

SM DeGuire, FS Ruggeri, MB Fares, A Chiki… - Journal of Biological …, 2018 - ASBMB
Huntington's disease is a fatal neurodegenerative disorder resulting from a CAG repeat
expansion in the first exon of the gene encoding the Huntingtin protein (Htt) …

Proteostasis in Huntington's disease: disease mechanisms and therapeutic opportunities

RJ Harding, Y Tong - Acta Pharmacologica Sinica, 2018 - nature.com
Many neurodegenerative diseases are characterized by impairment of protein quality control
mechanisms in neuronal cells. Ineffective clearance of misfolded proteins by the …

Traffic signaling: new functions of huntingtin and axonal transport in neurological disease

H Vitet, V Brandt, F Saudou - Current Opinion in Neurobiology, 2020 - Elsevier
Highlights•Subtle changes in axonal transport can modulate protein accumulation at the
synapse.•The huntingtin mutation underlying Huntington's disease disrupts axonal …

Interaction of huntingtin with PRMTs and its subsequent arginine methylation affects HTT solubility, phase transition behavior and neuronal toxicity

T Ratovitski, M Jiang, RN O'meally… - Human molecular …, 2022 - academic.oup.com
Huntington's disease (HD) is an incurable neurodegenerative disorder caused by a CAG
expansion in the huntingtin gene (HTT). Post-translational modifications of huntingtin protein …

How do post-translational modifications influence the pathomechanistic landscape of Huntington's disease? A comprehensive review

B Lontay, A Kiss, L Virág, K Tar - International journal of molecular …, 2020 - mdpi.com
Huntington's disease (HD) is an autosomal dominant inherited neurodegenerative disorder
characterized by the loss of motor control and cognitive ability, which eventually leads to …